US FDA approves Revolution Medicines pancreatic cancer drug
The US FDA has approved Revolution Medicines' pancreatic cancer drug, according to TradingView News.
Story updates
02:56:58 PM UTC
SquawkNews
FDA approves new pancreatic cancer drug expected to usher in new era of treatment - The therapy, Rasonque from Revolution Medicines, nearly doubled overall survival in a key clinical trial -- STAT News
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.